| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_202236a21cc868159a15abd61e9de67f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f3e04b44f258c7f603dd71afae13447
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_efce5f25e4bf569d11c0f2e7a6ba2eb2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-14 |
| filingDate |
2012-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_495e57a8f610acd7f87eff171d51a102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ef8fb59403bd08d92760cb55431cfe9 |
| publicationDate |
2015-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9206197-B2 |
| titleOfInvention |
Amorphous form of dolutegravir |
| abstract |
An amorphous form of dolutegravir sodium, pharmaceutical compositions comprising same, methods for its preparation and use thereof as an antiretroviral agent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017208105-A1 |
| priorityDate |
2011-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |